When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALX Oncology's main focus is the CD47 blocker evorpacept, which has shown encouraging results in combination with other therapies for various cancers.
The company has a strong financial position with enough runway to fund operations into early 2026.
There is both potential and risk associated with evorpacept, as it has shown positive early data but nothing convincing, so the long-term outlook is very unclear.